Entering text into the input field will update the search result below

Amarin Q4 results led by strong Vascepa sales

Feb. 25, 2021 9:48 AM ETAmarin Corporation plc (AMRN) StockAMRNBy: Jonathan Block, SA News Editor10 Comments
  • Amarin Corp. plc (NASDAQ:AMRN) reported Q4 2020 results today that beat analyst expectations on both EPS and revenue.
  • Revenue in the quarter was $167.3M, a 17% increase from the prior-year period, and a record for the company.
  • The record revenue

Recommended For You

About AMRN Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
AMRN--
Amarin Corporation plc